Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096
10.48
+2.85%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
10.48 on 9 Oct 2026
10 8 5 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $7.95 14 Oct 2025 $8.12 15 Oct 2025 $9.27 16 Oct 2025 $9.14 17 Oct 2025 $9.24 20 Oct 2025 $9.34 21 Oct 2025 $9.08 22 Oct 2025 $9.07 23 Oct 2025 $9.13 24 Oct 2025 $9.21 27 Oct 2025 $9.31 28 Oct 2025 $9.23 29 Oct 2025 $9.62 30 Oct 2025 $9.71 31 Oct 2025 $9.70 3 Nov 2025 $9.90 4 Nov 2025 $9.90 5 Nov 2025 $9.87 6 Nov 2025 $7.71 7 Nov 2025 $7.43 10 Nov 2025 $7.72 11 Nov 2025 $7.44 12 Nov 2025 $7.59 13 Nov 2025 $7.26 14 Nov 2025 $7.18 17 Nov 2025 $7.26 18 Nov 2025 $7.08 19 Nov 2025 $7.09 20 Nov 2025 $6.84 21 Nov 2025 $6.83 24 Nov 2025 $7.04 25 Nov 2025 $7.10 26 Nov 2025 $7.18 28 Nov 2025 $7.18 1 Dec 2025 $6.96 2 Dec 2025 $6.47 3 Dec 2025 $6.73 4 Dec 2025 $6.72 5 Dec 2025 $6.51 8 Dec 2025 $6.99 9 Dec 2025 $7.01 10 Dec 2025 $6.94 11 Dec 2025 $7.01 12 Dec 2025 $7.17 15 Dec 2025 $7.05 16 Dec 2025 $7.10 17 Dec 2025 $6.99 18 Dec 2025 $7.01 19 Dec 2025 $7.34 22 Dec 2025 $7.21 23 Dec 2025 $7.28 24 Dec 2025 $7.21 26 Dec 2025 $7.37 29 Dec 2025 $7.43 30 Dec 2025 $7.31 31 Dec 2025 $7.85 2 Jan 2026 $7.35 5 Jan 2026 $7.09 6 Jan 2026 $6.96 7 Jan 2026 $7.21 8 Jan 2026 $8.13 9 Jan 2026 $7.93 12 Jan 2026 $7.87 13 Jan 2026 $7.71 14 Jan 2026 $7.58 15 Jan 2026 $7.41 16 Jan 2026 $7.52 20 Jan 2026 $7.61 21 Jan 2026 $7.62 22 Jan 2026 $7.61 23 Jan 2026 $7.44 26 Jan 2026 $7.48 27 Jan 2026 $7.51 28 Jan 2026 $7.16 29 Jan 2026 $7.24 30 Jan 2026 $7.36 2 Feb 2026 $7.36 3 Feb 2026 $7.34 4 Feb 2026 $7.08 5 Feb 2026 $6.91 6 Feb 2026 $7.01 9 Feb 2026 $6.96 10 Feb 2026 $7.22 11 Feb 2026 $6.91 12 Feb 2026 $6.91 13 Feb 2026 $6.82 17 Feb 2026 $6.91 18 Feb 2026 $7.03 19 Feb 2026 $6.73 20 Feb 2026 $6.61 23 Feb 2026 $6.58 24 Feb 2026 $6.68 25 Feb 2026 $6.66 26 Feb 2026 $6.74 27 Feb 2026 $6.12 2 Mar 2026 $6.02 3 Mar 2026 $5.94 4 Mar 2026 $6.07 5 Mar 2026 $6.04 6 Mar 2026 $5.81 9 Mar 2026 $5.60 10 Mar 2026 $5.82 11 Mar 2026 $5.73 12 Mar 2026 $5.48 13 Mar 2026 $5.46 16 Mar 2026 $5.49 17 Mar 2026 $5.61 18 Mar 2026 $5.43 19 Mar 2026 $5.58 20 Mar 2026 $5.44 23 Mar 2026 $5.61 24 Mar 2026 $5.29 25 Mar 2026 $5.30 26 Mar 2026 $5.57 27 Mar 2026 $5.40 30 Mar 2026 $5.60 31 Mar 2026 $5.80 1 Apr 2026 $6.04 2 Apr 2026 $6.04 6 Apr 2026 $6.05 7 Apr 2026 $5.87 8 Apr 2026 $5.92 9 Apr 2026 $6.01 10 Apr 2026 $5.85 13 Apr 2026 $5.97 14 Apr 2026 $6.07 15 Apr 2026 $6.20 16 Apr 2026 $6.12 17 Apr 2026 $6.37 20 Apr 2026 $6.25 21 Apr 2026 $5.89 22 Apr 2026 $6.04 23 Apr 2026 $5.95 24 Apr 2026 $6.05 27 Apr 2026 $6.12 28 Apr 2026 $6.09 29 Apr 2026 $6.02 30 Apr 2026 $6.13 1 May 2026 $6.28 4 May 2026 $6.34 5 May 2026 $6.23 6 May 2026 $6.37 7 May 2026 $6.63 8 May 2026 $6.53 11 May 2026 $6.14 12 May 2026 $6.26 13 May 2026 $6.43 14 May 2026 $6.38 15 May 2026 $6.24 18 May 2026 $6.01 19 May 2026 $5.92 20 May 2026 $6.23 21 May 2026 $6.38 22 May 2026 $6.19 26 May 2026 $6.26 27 May 2026 $6.23 28 May 2026 $6.32 29 May 2026 $6.16 1 Jun 2026 $6.07 2 Jun 2026 $6.00 3 Jun 2026 $5.89 4 Jun 2026 $6.15 5 Jun 2026 $6.18 8 Jun 2026 $6.24 9 Jun 2026 $6.50 10 Jun 2026 $6.71 11 Jun 2026 $6.93 12 Jun 2026 $6.79 15 Jun 2026 $6.88 16 Jun 2026 $6.90 17 Jun 2026 $6.90 18 Jun 2026 $6.95 22 Jun 2026 $6.90 23 Jun 2026 $7.20 24 Jun 2026 $7.40 25 Jun 2026 $7.40 26 Jun 2026 $7.69 29 Jun 2026 $7.74 30 Jun 2026 $7.92 1 Jul 2026 $8.00 2 Jul 2026 $8.28 6 Jul 2026 $8.37 7 Jul 2026 $8.94 8 Jul 2026 $8.67 9 Jul 2026 $8.62 10 Jul 2026 $8.34 13 Jul 2026 $8.16 14 Jul 2026 $8.28 15 Jul 2026 $8.70 16 Jul 2026 $8.69 17 Jul 2026 $8.80 20 Jul 2026 $8.60 21 Jul 2026 $8.78 22 Jul 2026 $8.38 23 Jul 2026 $8.41 24 Jul 2026 $8.32 27 Jul 2026 $8.21 28 Jul 2026 $8.24 29 Jul 2026 $8.38 30 Jul 2026 $8.42 31 Jul 2026 $8.08 3 Aug 2026 $8.13 4 Aug 2026 $8.19 5 Aug 2026 $8.11 6 Aug 2026 $7.36 7 Aug 2026 $7.93 10 Aug 2026 $7.99 11 Aug 2026 $8.39 12 Aug 2026 $8.49 13 Aug 2026 $8.33 14 Aug 2026 $8.60 17 Aug 2026 $8.52 18 Aug 2026 $8.85 19 Aug 2026 $8.78 20 Aug 2026 $8.60 21 Aug 2026 $8.70 24 Aug 2026 $8.74 25 Aug 2026 $8.74 26 Aug 2026 $8.68 27 Aug 2026 $8.60 28 Aug 2026 $8.48 31 Aug 2026 $8.44 1 Sep 2026 $8.43 2 Sep 2026 $8.58 3 Sep 2026 $8.59 4 Sep 2026 $8.53 8 Sep 2026 $8.48 9 Sep 2026 $7.71 10 Sep 2026 $7.67 11 Sep 2026 $7.45 14 Sep 2026 $7.57 15 Sep 2026 $7.49 16 Sep 2026 $7.78 17 Sep 2026 $8.16 18 Sep 2026 $8.20 21 Sep 2026 $8.80 22 Sep 2026 $8.73 23 Sep 2026 $8.66 24 Sep 2026 $8.95 25 Sep 2026 $9.10 28 Sep 2026 $9.83 29 Sep 2026 $9.98 30 Sep 2026 $9.56 1 Oct 2026 $9.25 2 Oct 2026 $9.08 5 Oct 2026 $10.13 6 Oct 2026 $10.07 7 Oct 2026 $10.11 8 Oct 2026 $10.19 9 Oct 2026 $10.48 Hecht Beth See Remarks Sold on a plan $123.30K 11 Nov 2025 · at $7.40 · 1.2% of stake Shannon John Patrick Jr See Remarks Sold at will $173.40K 13 Nov 2025 · at $7.46 · 0.9% of stake Hecht Beth See Remarks Sold on a plan $116.78K 1 Dec 2025 · at $7.01 · 1.2% of stake BORMANN-KENNEDY BARBARA-JEAN … Director Sold on a plan $106.41K 12 Dec 2025 · at $7.09 · 9.5% of stake JOHNSON JOHN Director Sold at will $977.02K 19 Dec 2025 · at $7.22 · 16.2% of stake Hecht Beth See Remarks Sold on a plan $123.78K 2 Jan 2026 · at $7.43 · 1.3% of stake Shannon John Patrick Jr See Remarks Sold at will $176.26K 5 Jan 2026 · at $7.08 · 0.9% of stake McCulloch Kevin See Remarks Sold on a plan $120.00K 8 Jan 2026 · at $8.00 · 0.9% of stake Hecht Beth See Remarks Sold at will $124.15K 2 Feb 2026 · at $7.45 · 1.3% of stake Hecht Beth See Remarks Sold on a plan $104.09K 2 Mar 2026 · at $6.25 · 1.3% of stake Brady James Aloysius Director Sold on a plan $60.04K 30 Mar 2026 · at $5.54 · 10.8% of stake Hecht Beth See Remarks Sold on a plan $99.86K 1 Apr 2026 · at $5.99 · 1.4% of stake Hecht Beth See Remarks Sold on a plan $103.81K 1 May 2026 · at $6.23 · 1.4% of stake Hecht Beth See Remarks Sold on a plan $100.98K 1 Jun 2026 · at $6.06 · 1.4% of stake PERSKY MARLA Director Sold on a plan $91.43K 3 Jun 2026 · at $5.90 · 10.9% of stake JOHNSON JOHN Director Sold on a plan $91.42K 4 Jun 2026 · at $6.09 · 2.1% of stake BORMANN-KENNEDY BARBARA-JEAN … Director Sold on a plan $97.51K 4 Jun 2026 · at $6.09 · 11.2% of stake HALKUFF DAWN Director Sold on a plan $121.89K 4 Jun 2026 · at $6.09 · 17.4% of stake Hecht Beth See Remarks Sold on a plan $133.86K 1 Jul 2026 · at $8.03 · 1.4% of stake McCulloch Kevin See Remarks Sold on a plan $722.51K 1 Jul 2026 · at $8.03 · 5.1% of stake Pieper Steven See Remarks Sold on a plan $147.90K 6 Jul 2026 · at $8.50 · 1.2% of stake Pieper Steven See Remarks Sold on a plan $235.28K 7 Jul 2026 · at $8.52 · 2.0% of stake McCulloch Kevin See Remarks Sold on a plan $120.24K 3 Aug 2026 · at $8.02 · 0.9% of stake Hecht Beth See Remarks Sold on a plan $133.55K 3 Aug 2026 · at $8.01 · 1.4% of stake Pieper Steven See Remarks Sold on a plan $42.50K 12 Aug 2026 · at $8.50 · 0.4% of stake Pieper Steven See Remarks Sold on a plan $42.50K 1 Sep 2026 · at $8.50 · 0.4% of stake McCulloch Kevin See Remarks Sold on a plan $127.31K 1 Sep 2026 · at $8.49 · 0.9% of stake Hecht Beth See Remarks Sold on a plan $141.43K 1 Sep 2026 · at $8.49 · 1.5% of stake McCulloch Kevin See Remarks Sold on a plan $250.00K 28 Sep 2026 · at $10.00 · 1.5% of stake Pieper Steven See Remarks Sold on a plan $47.04K 1 Oct 2026 · at $9.41 · 0.4% of stake McCulloch Kevin See Remarks Sold on a plan $141.12K 1 Oct 2026 · at $9.41 · 0.9% of stake Hecht Beth See Remarks Sold on a plan $156.79K 1 Oct 2026 · at $9.41 · 1.5% of stake
0 buys4 sales at will28 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$291.85M
Net income
$554.00K
Free cash flow
$28.63M
Operating margin
8.5%
Net margin
0.2%
Return on equity
4.1%
Return on capital
10.6%
Debt to equity
16.10
Revenue growth, 1 yr
43.7%
Revenue growth, 5 yr
70.7% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
20M -91M FY20 Fiscal year 2020 Revenue $20.16M Net income $91.14M Margin -452.2% 50M -123M FY21 Fiscal year 2021 Revenue $49.59M Net income $122.73M Margin -247.5% · growth +146.0% 110M -95M FY22 Fiscal year 2022 Revenue $110.25M Net income $94.66M Margin -85.9% · growth +122.3% 164M -62M FY23 Fiscal year 2023 Revenue $163.91M Net income $62.26M Margin -38.0% · growth +48.7% 203M -55M FY24 Fiscal year 2024 Revenue $203.07M Net income $54.84M Margin -27.0% · growth +23.9% 292M 554K FY25 Fiscal year 2025 Revenue $291.85M Net income $554.00K Margin 0.2% · growth +43.7%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
1 Oct 2026 Hecht Beth
See Remarks
Sold on a plan $156.79K 1.5%
1 Oct 2026 McCulloch Kevin
See Remarks
Sold on a plan $141.12K 0.9%
1 Oct 2026 Pieper Steven
See Remarks
Sold on a plan $47.04K 0.4%
28 Sep 2026 McCulloch Kevin
See Remarks
Sold on a plan $250.00K 1.5%
1 Sep 2026 Hecht Beth
See Remarks
Sold on a plan $141.43K 1.5%
1 Sep 2026 McCulloch Kevin
See Remarks
Sold on a plan $127.31K 0.9%